litlas
Log inCreate account

William U. Shipley

Active 1974–2025

Also published as
WILLIAM U. SHIPLEY
129
Papers
29,853
Citations
95
h-index
127
i10-index

Citations

Citations per year for William U. Shipley1931: 2 citations1975: 1 citations1976: 1 citations1977: 2 citations1978: 3 citations1980: 4 citations1981: 2 citations1982: 10 citations1983: 5 citations1984: 18 citations1985: 15 citations1986: 11 citations1987: 17 citations1988: 19 citations1989: 15 citations1990: 17 citations1991: 37 citations1992: 17 citations1993: 46 citations1994: 48 citations1995: 72 citations1996: 55 citations1997: 69 citations1998: 91 citations1999: 90 citations2000: 92 citations2001: 76 citations2002: 108 citations2003: 126 citations2004: 115 citations2005: 144 citations2006: 124 citations2007: 195 citations2008: 172 citations2009: 153 citations2010: 188 citations2011: 146 citations2012: 136 citations2013: 165 citations2014: 192 citations2015: 96 citations2016: 140 citations2017: 167 citations2018: 110 citations2019: 527 citations2020: 583 citations2021: 430 citations2022: 301 citations2023: 264 citations2024: 433 citations2025: 161 citations2026: 7 citations1932–1974: no citations, so these years are not shown1979: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,105 citing papers, 32% of this breakdownCanada: 443 citing papers, 6.7% of this breakdownUnited Kingdom: 440 citing papers, 6.7% of this breakdownGermany: 376 citing papers, 5.7% of this breakdownChina: 344 citing papers, 5.2% of this breakdownItaly: 318 citing papers, 4.8% of this breakdownFrance: 267 citing papers, 4.1% of this breakdownNetherlands: 250 citing papers, 3.8% of this breakdownAustralia: 184 citing papers, 2.8% of this breakdownSwitzerland: 167 citing papers, 2.5% of this breakdownJapan: 167 citing papers, 2.5% of this breakdownBelgium: 152 citing papers, 2.3% of this breakdown
0%32%Other 20.9%

Institutions

Fields

  • Medicine83.7%
  • Biochemistry, Genetics and Molecular Biology8.7%
  • Physics and Astronomy3.5%
  • Engineering0.9%
  • Immunology and Microbiology0.8%
  • Computer Science0.5%
  • Other1.9%

Topics

  • Prostate Cancer Diagnosis and Treatment16%
  • Prostate Cancer Treatment and Research14.1%
  • Advanced Radiotherapy Techniques7.8%
  • Bladder and Urothelial Cancer Treatments7.2%
  • Urinary and Genital Oncology Studies4.4%
  • Urinary Bladder and Prostate Research1.8%
  • Other48.7%

Coauthors

All papers

Open in search
  1. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

    Authors: Mack Roach, Gerald E. Hanks, Howard D. Thames, Paul F. Schellhammer, William U. Shipley, Gerald H. Sokol, Howard M. Sandler - International Journal of Radiation Oncology*Biology*Physics 2006 cited by 2,733

  2. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis

    Authors: Alexandre R. Zlotta, Leslie Ballas, Andrzej Niemierko, Katherine Lajkosz, Cynthia Kuk, Gus Miranda, Michael Drumm, Andrea Mari, Ethan Thio, Neil Fleshner, Girish S. Kulkarni, Michael A.S. Jewett, Robert G. Bristow, Charles Catton, Alejandro Berlín, Srikala S. Sridhar, Anne Schuckman, Adam S. Feldman, Matthew Wszolek, Douglas M. Dahl, Richard J. Lee, Philip J. Saylor, M. Dror Michaelson, David T. Miyamoto, Anthony L. Zietman, William U. Shipley, Peter Chung, Siamak Daneshmand, Jason A. Efstathiou - The Lancet Oncology 2023 cited by 245

  3. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience

    Authors: Nicholas J. Giacalone, William U. Shipley, R.H. Clayman, Andrzej Niemierko, Michael Drumm, Niall M. Heney, M. Dror Michaelson, Richard J. Lee, Philip J. Saylor, Matthew Wszolek, Adam S. Feldman, Douglas M. Dahl, Anthony L. Zietman, Jason A. Efstathiou - European Urology 2017 cited by 400

  4. Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality

    Authors: Robert T. Dess, Holly Hartman, Brandon A. Mahal, Payal Soni, Will Jackson, Matthew R. Cooperberg, Christopher L. Amling, William J. Aronson, Christopher J. Kane, Martha K. Terris, Zachary S. Zumsteg, Santino Butler, Joseph R. Osborne, Todd M. Morgan, Rohit Mehra, Simpa S. Salami, Amar U. Kishan, Chenyang Wang, Edward M. Schaeffer, Mack Roach, Thomas M. Pisansky, William U. Shipley, Stephen J. Freedland, Howard M. Sandler, Susan Halabi, Felix Y. Feng, James J. Dignam, Paul L. Nguyen, Matthew J. Schipper, Daniel E. Spratt - JAMA Oncology 2019 cited by 409

  5. Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

    Authors: William U. Shipley, Wendy Seiferheld, Himanshu Lukka, Pierre Major, Niall M. Heney, David J. Grignon, Oliver Sartor, Maltibehn P. Patel, Jean-Paul Bahary, Anthony L. Zietman, Thomas M. Pisansky, Kenneth L. Zeitzer, C.A. Lawton, Felix Y. Feng, R.D. Lovett, Alexander G. Balogh, Luís Souhami, Seth A. Rosenthal, K. Kerlin, James J. Dignam, Stephanie L. Pugh, Howard M. Sandler - New England Journal of Medicine 2017 cited by 662

  6. Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233

    Authors: Raymond H. Mak, Daniel Hunt, William U. Shipley, Jason A. Efstathiou, William Tester, Michael P. Hagan, Donald S. Kaufman, Niall M. Heney, Anthony L. Zietman - Journal of Clinical Oncology 2014 cited by 452

  7. Bladder cancer

    Authors: Donald S. Kaufman, William U. Shipley, Adam S. Feldman - The Lancet 2009 cited by 997

  8. Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer

    Authors: Felix Y. Feng, Huei–Chung Huang, Daniel E. Spratt, Shuang G. Zhao, Howard M. Sandler, Jeffry Simko, Elai Davicioni, Paul L. Nguyen, Alan Pollack, Jason A. Efstathiou, Adam P. Dicker, Tamara R. Todorović, Jennifer Margrave, Yang Liu, Bashar Dabbas, Darby J. S. Thompson, Rajdeep Das, James J. Dignam, Christopher Sweeney, Gerhardt Attard, Jean-Paul Bahary, Himanshu Lukka, William A. Hall, Thomas M. Pisansky, Amit B. Shah, Stephanie L. Pugh, William U. Shipley, Phuoc T. Tran - JAMA Oncology 2021 cited by 148

  9. Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712—A Randomized Phase II Trial

    Authors: John J. Coen, Peixin Zhang, Philip J. Saylor, Cheryl T. Lee, Chin‐Lee Wu, William A. Parker, Timothy Lautenschlaeger, Anthony L. Zietman, Jason A. Efstathiou, Ashesh B. Jani, Ömer Küçük, Luís Souhami, Joseph P. Rodgers, Howard M. Sandler, William U. Shipley - Journal of Clinical Oncology 2018 cited by 145

  10. Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer

    Authors: Christopher U. Jones, Daniel Hunt, D.G. McGowan, Mahul B. Amin, Michael Chetner, Deborah Watkins Bruner, Mark H. Leibenhaut, Siraj Husain, Marvin Rotman, Luís Souhami, Howard M. Sandler, William U. Shipley - New England Journal of Medicine 2011 cited by 701

  11. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial

    Authors: Mack Roach, Jennifer Moughan, C.A. Lawton, Adam P. Dicker, Kenneth L. Zeitzer, Elizabeth Gore, Young Kwok, Michael J. Seider, I‐Chow Hsu, Alan C. Hartford, Eric M. Horwitz, Kosj Yamoah, Christopher U. Jones, Jeff M. Michalski, W. Robert Lee, Thomas M. Pisansky, Rachel Rabinovitch, Marvin Rotman, Rodger M. Pryzant, Harold E. Kim, Charles R. Thomas, William U. Shipley, Howard M. Sandler - The Lancet Oncology 2018 cited by 231

  12. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer

    Authors: Kimberley S. Mak, Angela Smith, Alec Eidelman, R.H. Clayman, Andrzej Niemierko, Jed-Sian Cheng, Jonathan Matthews, Michael Drumm, Matthew E. Nielsen, Adam S. Feldman, Richard J. Lee, Anthony L. Zietman, Ronald C. Chen, William U. Shipley, Matthew I. Milowsky, Jason A. Efstathiou - International Journal of Radiation Oncology*Biology*Physics 2016 cited by 161

  13. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

    Authors: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, Niall M. Heney, Donald S. Kaufman, Andrzej Niemierko, John J. Coen, Rafi Y. Skowronski, Jonathan J. Paly, Francis J. McGovern, Anthony L. Zietman - European Urology 2011 cited by 427

  14. Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review

    Authors: Guillaume Ploussard, Siamak Daneshmand, Jason A. Efstathiou, Harry W. Herr, Nicholas D. James, Claus Rödel, Shahrokh F. Shariat, William U. Shipley, Cora N. Sternberg, George N. Thalmann, Wassim Kassouf - European Urology 2014 cited by 358

  15. Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial

    Authors: Тимур Митин, Daniel Hunt, William U. Shipley, Donald S. Kaufman, Robert G. Uzzo, Chin‐Lee Wu, Mark K. Buyyounouski, Howard M. Sandler, Anthony L. Zietman - The Lancet Oncology 2013 cited by 159

  16. Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer

    Authors: Robert T. Dess, Yilun Sun, Will Jackson, Neil Jairath, Amar U. Kishan, David G. Wallington, Brandon A. Mahal, Bradley J. Stish, Z.S. Zumsteg, Robert B. Den, William A. Hall, Laila A. Gharzai, E Jaworski, Zachary Reichert, Todd M. Morgan, Rohit Mehra, Edward M. Schaeffer, Oliver Sartor, Paul L. Nguyen, W. Robert Lee, Seth A. Rosenthal, Jeff M. Michalski, Matthew J. Schipper, James J. Dignam, Thomas M. Pisansky, Anthony L. Zietman, Howard M. Sandler, Jason A. Efstathiou, Felix Y. Feng, William U. Shipley, Daniel E. Spratt - JAMA Oncology 2020 cited by 102

  17. Penile Cancer

    Authors: Peter E. Clark, Philippe E. Spiess, Neeraj Agarwal, Matthew C. Biagioli, Mario A. Eisenberger, Richard E. Greenberg, Harry W. Herr, Brant A. Inman, Deborah A. Kuban, Timothy M. Kuzel, Subodh M. Lele, Jeff M. Michalski, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Jerome P. Richie, Wade J. Sexton, William U. Shipley, Eric J. Small, Donald L. Trump, Geoffrey Wile, Timothy G. Wilson, Mary A. Dwyer, Maria Ho - Journal of the National Comprehensive Cancer Network 2013 cited by 185

  18. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.

    Authors: William U. Shipley, Kathryn Winter, Donald S. Kaufman, W. Robert Lee, N.M. Heney, William Tester, Bryan Donnelly, Peter Venner, Cirilo Pérez, K.J. Murray, Reuben S. Doggett, Lawrence D. True - Journal of Clinical Oncology 1998 cited by 490

  19. Radiation Dose–Volume Effects of the Urinary Bladder

    Authors: Akila N. Viswanathan, Ellen Yorke, Lawrence B. Marks, Patricia J. Eifel, William U. Shipley - International Journal of Radiation Oncology*Biology*Physics 2010 cited by 399

  20. Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate

    Authors: Anthony L. Zietman, Michelle DeSilvio, Jerry D. Slater, Carl J. Rossi, Daniel W. Miller, Judith Adams, William U. Shipley - JAMA 2005 cited by 1,228

  21. Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09

    Authors: Anthony L. Zietman, Kyounghwa Bae, Jerry D. Slater, William U. Shipley, Jason A. Efstathiou, John J. Coen, David A. Bush, M. Lunt, Daphna Y. Spiegel, Rafi Y. Skowronski, B. Rodney Jabola, Carl J. Rossi - Journal of Clinical Oncology 2010 cited by 743

  22. Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06

    Authors: Jason A. Efstathiou, Kyounghwa Bae, William U. Shipley, Donald S. Kaufman, Michael P. Hagan, Niall M. Heney, Howard M. Sandler - Journal of Clinical Oncology 2009 cited by 219

  23. Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910

    Authors: Thomas M. Pisansky, Daniel Hunt, Leonard G. Gomella, Mahul B. Amin, Alexander G. Balogh, Daniel M. Chinn, Michael J. Seider, Marie Duclos, Seth A. Rosenthal, Glenn Bauman, Elizabeth Gore, Marvin Rotman, Himanshu Lukka, William U. Shipley, James J. Dignam, Howard M. Sandler - Journal of Clinical Oncology 2014 cited by 139

  24. Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial

    Authors: Christopher U. Jones, Stephanie L. Pugh, Howard M. Sandler, Michael Chetner, Mahul B. Amin, Deborah Watkins Bruner, Anthony L. Zietman, Robert B. Den, Mark H. Leibenhaut, J.M. Longo, Jean-Paul Bahary, Seth A. Rosenthal, Luís Souhami, Jeff M. Michalski, Alan C. Hartford, Pradip Amin, Mack Roach, Don Yee, Jason A. Efstathiou, Joseph P. Rodgers, Felix Y. Feng, William U. Shipley - International Journal of Radiation Oncology*Biology*Physics 2021 cited by 41